Other News

Cardiovascular Systems, Inc. Announces Commercial Launch in Japan

First Patient Treated by Dr. Shigeru Saito at Shonan Kamakura General Hospital ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has commercially treated the first patient in […]

Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure NASDAQ, TSX: NVCN VANCOUVER, Feb. 1, 2018 /PRNewswire/ – Neovasc, Inc. (NVCN) (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies, today announced that the “Institut für das Entgeltsystem im […]

Successful Clinical Application of China’s First Transcatheter Mitral Valve Repair Device, MitralStitch

HANGZHOU, China, Feb. 1, 2018 /PRNewswire/ — On January 19, 2018, the global first clinical case of MitralStitch™ mitral valve repair system was completed at Yunnan Fuwai Hospital, China. This operation was jointly performed by the team of Professor Pan Xiangbin and Professor Meng Xu from Beijing Anzhen Hospital under the guidance of Academician Hu Shengshou […]

LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery

Company celebrates new design that delivers improved flexibility, clarity and control LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has achieved CE Mark for its new PureFlexTM line of adult arterial cannulae. Engineered to improve the critical link between the patient and extracorporeal circulation, […]

Aegis Sciences Launches First-of-Its Kind Cardiovascular Medication Adherence Tool to Help Physicians Manage Patients with Uncontrolled Hypertension

KardiAssureTM provides doctors with clinical insight to improve patient outcomes and address non-adherence of more than 50 cardiovascular medications NASHVILLE, Tenn.–(BUSINESS WIRE)– Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers, today launched KardiAssureTM, a first-of-its-kind urinalysis that helps healthcare providers monitor cardiovascular medication […]

The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%

LONDON, Jan. 31, 2018 /PRNewswire/ — The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other […]

Boston Scientific’s Ranger DCB and Medtronic’s In.Pact Admiral DCB – Head to Head

This first of it’s kind trial compares two leading DCB technologies. Boston Scientific’s drug-coated balloon goes up against Medtronic’s DCB in first-of-its-kind trial JANUARY 31, 2018 BY SARAH FAULKNER, Drug Delivery Business NEws Top-line results from a head-to-head trial comparing Boston Scientific‘s (NYSE:BSX) Ranger drug-coated balloon and Medtronic‘s (NYSE:MDT) In.Pact Admiral DCB found no […]